BETIMOL, created in 2000 (Japan), from 33 sister brands and 17477 competing brands. BETIMOL is a brand of Santen Pharmaceutical, listed on the stock exchange of Francfort. The ISIN, the company's International Securities Identification Number, is JP3336000009. BETIMOL belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Santen Pharmaceutical
(BETIMOL)
over 5 years*
EUR 6.20